IMBIQ — Legacy IMBDS Income Statement
0.000.00%
Last trade - 00:00
- $0.00m
- $169.59m
- $544.56m
- 35
- 92
- 17
- 46
2019 February 2nd | 2020 February 1st | 2021 January 30th | 2022 January 29th | 2023 January 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | PRESS |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 597 | 502 | 454 | 551 | 545 |
Cost of Revenue | |||||
Gross Profit | 207 | 164 | 167 | 223 | 210 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 615 | 554 | 462 | 563 | 592 |
Operating Profit | -18.6 | -52.5 | -7.94 | -11.4 | -47.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -22.1 | -56.3 | -13.2 | -22.9 | -70.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -22.2 | -56.3 | -13.2 | -23 | -70.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -22.2 | -56.3 | -13.2 | -22 | -70 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -22.2 | -56.3 | -13.2 | -22 | -70 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.06 | -5.92 | -1.12 | -0.838 | -1.9 |